Vitamin B12 and bone loss
This article was originally published in The Tan Sheet
Executive Summary
Low serum levels of vitamin B12 in elderly women is associated with more rapid bone loss from the hip than women with higher levels of vitamin B12, but is not associated with greater heel-area (calcaneal) bone loss, Katie Stone, University of California, San Francisco, et al. find in the March Journal of Clinical Endocrinology & Metabolism. The retrospective cohort study was completed by 77 women, age 65 or older. At baseline visit, women gave a blood sample, had a calcaneal bone mineral density measurement and completed a questionnaire on supplement use and food frequency. Repeat measurements of calcaneal and hip BMD were repeated 3.5 and 5.9 years later. The collection of serum samples before measurement of change in bone mass is one of the study's strengths, researchers say...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.